IMR Press / FBS / Volume 9 / Issue 2 / DOI: 10.2741/S485

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Racial disparities: disruptive genes in prostate carcinogenesis

Show Less
1 Department of Biological Sciences, Cleveland State University, Cleveland, Ohio, USA,
2 Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, Ohio, USA

*Author to whom correspondence should be addressed.


Front. Biosci. (Schol Ed) 2017, 9(2), 244–253;
Published: 1 March 2017

Population specific studies in prostate cancer (PCa) reveal a unique heterogeneous etiology. Various factors, such as genetics, environment and dietary regimen seems to determine disease progression, therapeutic resistance and rate of mortality. Enormous disparity documented in disease incidences, aggressiveness and mortality in PCa among AAs (African Americans) and CAs (Caucasian Americans) is attributed to the variations in genetics, epigenetics and their association with metabolism. Scientific and clinical evidences have revealed the influence of variations in Androgen Receptor (AR), RNAse L, macrophage scavenger receptor 1 (MRS1), androgen metabolism by cytochrome P450 3A4, differential regulation of microRNAs, epigenetic alterations and diet in racial disparity in PCa incidences and mortality. Concerted efforts are needed to identify race specific prognostic markers and treatment regimen for a better management of the disease.

Androgen Receptor
RNase L
Prostate Cancer
Cancer Disparity
Back to top